Integer (NYSE:ITGR – Get Free Report) and Milestone Scientific (NYSE:MLSS – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.
Analyst Recommendations
This is a summary of recent recommendations for Integer and Milestone Scientific, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Integer | 0 | 11 | 1 | 0 | 2.08 |
| Milestone Scientific | 0 | 0 | 1 | 0 | 3.00 |
Integer currently has a consensus price target of $113.67, suggesting a potential downside of 10.49%. Milestone Scientific has a consensus price target of $1.00, suggesting a potential upside of 316.67%. Given Milestone Scientific’s stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than Integer.
Insider & Institutional Ownership
99.3% of Integer shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 1.1% of Integer shares are owned by insiders. Comparatively, 9.2% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Earnings & Valuation
This table compares Integer and Milestone Scientific”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Integer | $1.85 billion | 2.33 | $102.81 million | $2.98 | 42.61 |
| Milestone Scientific | $9.28 million | 2.34 | -$6.93 million | ($0.04) | -6.00 |
Integer has higher revenue and earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Integer has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.
Profitability
This table compares Integer and Milestone Scientific’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Integer | 5.68% | 11.84% | 5.98% |
| Milestone Scientific | -52.01% | -60.26% | -40.23% |
Summary
Integer beats Milestone Scientific on 8 of the 13 factors compared between the two stocks.
About Integer
Integer Holdings Corporation develops and manufactures medical-device components and provides outsourced manufacturing services for medical technology companies. Its products are used in devices for cardiac rhythm management, neuromodulation, cardiovascular care, and other medical applications. The company’s offerings include batteries, capacitors, leads, catheters, and precision components, as well as engineered assemblies and manufacturing support. Integer serves medical-device original equipment manufacturers around the world.
About Milestone Scientific
Milestone Scientific develops and commercializes computer-controlled drug-delivery instruments for dental and medical applications. Its technology is designed to regulate the flow and pressure of injections, with the aim of improving control and reducing discomfort during procedures. In dentistry, the company offers systems including the STA Single Tooth Anesthesia System and CompuDent, which are used to deliver local anesthetic. Its medical products include the CompuFlo system, designed for applications such as epidural injections and other procedures involving controlled drug delivery.
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
